Matifat, E.
Berger Pelletier, E.
Brison, R.
Hébert, L. J.
Roy, J.-S.
Woodhouse, L.
Berthelot, S.
Daoust, R.
Sirois, M.-J.
Booth, R.
Gagnon, R.
Miller, J.
Tousignant-Laflamme, Y.
Emond, M.
Perreault, K.
Desmeules, F.
Funding for this research was provided by:
Canadian Institutes of Health Research (202010PJT-451693-CIB-CFCC-130299)
Article History
Received: 11 November 2022
Accepted: 18 January 2023
First Online: 6 February 2023
Declarations
:
: This study was approved by the Research Ethics Committee of the CIUSSS-de-l’Est-de-l’Ile-de-Montréal (MP-12-2022-2730). This study will be undertaken following approval from the ethics review boards of all participating EDs.In regard to participants’ consent, research professionals in each site will explain the study, including the purpose and the required implication by participants, to eligible patients and will answer any remaining questions. Research professionals will then obtain written informed consent from patients who agree to enroll in this study. Information and consent forms will be available in both French and English, depending on the participants’ preferred language.
: Not applicable. No identifying images or other personal or clinical details of participants are presented here nor will be presented in reports of the trial results. Informed consent materials are available from the corresponding author upon request.
: The authors declare that they have no competing interests.